Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Toltrazuril Sulfone
2. 69004-04-2
3. Toltrazuril (sulfone)
4. 1-methyl-3-{3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl}-1,3,5-triazine-2,4,6(1h,3h,5h)-trione
5. Ponazuril [inn]
6. 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione
7. Jpw84as66u
8. Ncgc00182044-01
9. 1-methyl-3-(4-(p-((trifluoromethyl)sulfonyl)phenoxy)-m-tolyl)-s-triazine-2,4,6(1h,3h,5h)-trione.
10. Marquis
11. 1-methyl-3-(4-(p-((trifluoromethyl)sulfonyl)phenoxy)-m-tolyl)-s-triazine-2,4,6(1h,3h,5h)-trione
12. Unii-jpw84as66u
13. Bay-vi 9143
14. Marquis (vet Use Only)
15. Ponazuril [mi]
16. Dsstox_cid_28884
17. Dsstox_rid_83152
18. Dsstox_gsid_48958
19. Schembl203030
20. Ponazuril [green Book]
21. Acd855
22. Chembl2104856
23. Dtxsid7048958
24. Gtpl12223
25. Acd-855
26. Bcp14930
27. Tox21_113390
28. Zinc33854754
29. Ponazuril 100 Microg/ml In Methanol
30. Akos025312522
31. Cs-0615
32. Db11452
33. Ncgc00182044-02
34. Ac-28364
35. As-74844
36. Hy-17008
37. Cas-69004-04-2
38. Ft-0673975
39. D95987
40. 774p233
41. A836307
42. Q7227567
43. Toltrazuril Sulfone, Vetranal(tm), Analytical Standard
44. 1-methyl-3-[3-methyl-4-(4-trifluoromethanesulfonylphenoxy)phenyl]-1,3,5-triazinane-2,4,6-trione
45. 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione;toltrazuril Sulfone
Molecular Weight | 457.4 g/mol |
---|---|
Molecular Formula | C18H14F3N3O6S |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 4 |
Exact Mass | 457.05554083 g/mol |
Monoisotopic Mass | 457.05554083 g/mol |
Topological Polar Surface Area | 122 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 836 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Ponazuril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ponazuril, including repackagers and relabelers. The FDA regulates Ponazuril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ponazuril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ponazuril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ponazuril supplier is an individual or a company that provides Ponazuril active pharmaceutical ingredient (API) or Ponazuril finished formulations upon request. The Ponazuril suppliers may include Ponazuril API manufacturers, exporters, distributors and traders.
click here to find a list of Ponazuril suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ponazuril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ponazuril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ponazuril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ponazuril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ponazuril NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ponazuril suppliers with NDC on PharmaCompass.
Ponazuril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ponazuril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ponazuril GMP manufacturer or Ponazuril GMP API supplier for your needs.
A Ponazuril CoA (Certificate of Analysis) is a formal document that attests to Ponazuril's compliance with Ponazuril specifications and serves as a tool for batch-level quality control.
Ponazuril CoA mostly includes findings from lab analyses of a specific batch. For each Ponazuril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ponazuril may be tested according to a variety of international standards, such as European Pharmacopoeia (Ponazuril EP), Ponazuril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ponazuril USP).
LOOKING FOR A SUPPLIER?